TLR9 and idiopathic pulmonary fibrosis: In agreement with this, we analyzed expression of TDO2 in isolated fibroblasts from both patients with IPF and blm-treated mice treated with the TLR9 agonist ODN2395, and saw significant upregulation in both (Figure 6, B and D).